Literature DB >> 21041960

Central modulation of pain.

Michael H Ossipov1, Gregory O Dussor, Frank Porreca.   

Abstract

It has long been appreciated that the experience of pain is highly variable between individuals. Pain results from activation of sensory receptors specialized to detect actual or impending tissue damage (i.e., nociceptors). However, a direct correlation between activation of nociceptors and the sensory experience of pain is not always apparent. Even in cases in which the severity of injury appears similar, individual pain experiences may vary dramatically. Emotional state, degree of anxiety, attention and distraction, past experiences, memories, and many other factors can either enhance or diminish the pain experience. Here, we review evidence for "top-down" modulatory circuits that profoundly change the sensory experience of pain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21041960      PMCID: PMC2964993          DOI: 10.1172/JCI43766

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  148 in total

1.  Facilitation and attenuation of a visceral nociceptive reflex from the rostroventral medulla in the rat.

Authors:  Min Zhuo; G F Gebhart
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

2.  Putative nociceptive modulating neurons in the rostral ventromedial medulla of the rat: firing of on- and off-cells is related to nociceptive responsiveness.

Authors:  M M Heinricher; N M Barbaro; H L Fields
Journal:  Somatosens Mot Res       Date:  1989       Impact factor: 1.111

3.  The role of mu and kappa opioid receptors within the periaqueductal gray in the expression of conditional hypoalgesia.

Authors:  P S Bellgowan; F J Helmstetter
Journal:  Brain Res       Date:  1998-04-27       Impact factor: 3.252

4.  Diffuse noxious inhibitory controls of lumbar spinal neurons involve a supraspinal loop in the cat.

Authors:  C R Morton; B Maisch; M Zimmermann
Journal:  Brain Res       Date:  1987-05-05       Impact factor: 3.252

5.  Afferent connections of the rostral medulla of the cat: a neural substrate for midbrain-medullary interactions in the modulation of pain.

Authors:  I A Abols; A I Basbaum
Journal:  J Comp Neurol       Date:  1981-09-10       Impact factor: 3.215

Review 6.  Bad news from the brain: descending 5-HT pathways that control spinal pain processing.

Authors:  Rie Suzuki; Lars J Rygh; Anthony H Dickenson
Journal:  Trends Pharmacol Sci       Date:  2004-12       Impact factor: 14.819

7.  Kappa opioid receptor (KOR) and GAD67 immunoreactivity are found in OFF and NEUTRAL cells in the rostral ventromedial medulla.

Authors:  Clayton W Winkler; Sam M Hermes; Charles I Chavkin; Carrie T Drake; Shaun F Morrison; Sue A Aicher
Journal:  J Neurophysiol       Date:  2006-09-27       Impact factor: 2.714

8.  Enhanced group III mGluR-mediated inhibition of pain-related synaptic plasticity in the amygdala.

Authors:  Jeong S Han; Gary C Bird; Volker Neugebauer
Journal:  Neuropharmacology       Date:  2004-06       Impact factor: 5.250

9.  The density and distribution of serotonergic appositions onto identified neurons in the rat rostral ventromedial medulla.

Authors:  S B Potrebic; P Mason; H L Fields
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

10.  Effects of intrathecally administered methysergide and yohimbine on microstimulation-produced antinociception in the rat.

Authors:  N M Barbaro; D L Hammond; H L Fields
Journal:  Brain Res       Date:  1985-09-23       Impact factor: 3.252

View more
  297 in total

1.  The activation of supraspinal GPR40/FFA1 receptor signalling regulates the descending pain control system.

Authors:  K Nakamoto; T Nishinaka; N Sato; F Aizawa; T Yamashita; M Mankura; Y Koyama; F Kasuya; S Tokuyama
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

2.  Dissociating anticipation from perception: Acute pain activates default mode network.

Authors:  Aram Ter Minassian; Emmanuel Ricalens; Stanislas Humbert; Flavie Duc; Christophe Aubé; Laurent Beydon
Journal:  Hum Brain Mapp       Date:  2012-03-22       Impact factor: 5.038

Review 3.  Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.

Authors:  Claire Gavériaux-Ruff; Brigitte Lina Kieffer
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

Review 4.  Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

5.  Recent advances toward understanding the mysteries of the acute to chronic pain transition.

Authors:  Theodore J Price; Pradipta R Ray
Journal:  Curr Opin Physiol       Date:  2019-06-04

Review 6.  Developing an optimized strategy with transcranial direct current stimulation to enhance the endogenous pain control system in fibromyalgia.

Authors:  Dante Duarte; Luis Eduardo Coutinho Castelo-Branco; Elif Uygur Kucukseymen; Felipe Fregni
Journal:  Expert Rev Med Devices       Date:  2018-12-03       Impact factor: 3.166

7.  Opioid signaling in mast cells regulates injury responses associated with heterotopic ossification.

Authors:  Lixin Kan; Amelia A Mutso; Tammy L McGuire; Apkar Vania Apkarian; John A Kessler
Journal:  Inflamm Res       Date:  2013-12-11       Impact factor: 4.575

Review 8.  Epigenetic mechanisms of chronic pain.

Authors:  Giannina Descalzi; Daigo Ikegami; Toshikazu Ushijima; Eric J Nestler; Venetia Zachariou; Minoru Narita
Journal:  Trends Neurosci       Date:  2015-03-09       Impact factor: 13.837

Review 9.  Towards a mechanism-based approach to pain management in osteoarthritis.

Authors:  Anne-Marie Malfait; Thomas J Schnitzer
Journal:  Nat Rev Rheumatol       Date:  2013-09-17       Impact factor: 20.543

10.  Placebo and Active Treatment Additivity in Placebo Analgesia: Research to Date and Future Directions.

Authors:  Matthew J Coleshill; Louise Sharpe; Luana Colloca; Robert Zachariae; Ben Colagiuri
Journal:  Int Rev Neurobiol       Date:  2018-08-06       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.